A Study Of Pelvic Radiation On Urinary Incontinence And Voiding Dysfunction In Men With Urethral Slings

Overview

About this study

The purpose of this study is to evaluate urinary outcomes in male patients who receive pelvic radiation therapy following sling placement for stress urinary incontinence (SUI), with comparison to patients receiving radiation prior to sling or no radiation at all.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All male patients age ≥18 years who had a urethral sling procedure.

Exclusion Criteria:

  • Patients with prior artificial urinary sphincter placement, known neurogenic bladder, or less than 3 months of follow-up.

Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/27/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Elizabeth Bearrick, M.D.

Contact us for the latest status

Rochester, Minn.

Mayo Clinic principal investigator

J Warner, M.D.

Contact us for the latest status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Bridget Findlay, M.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions